Skip to main content

Product Persistence in GI Tract

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
1 program
SBD111 Probiotic Medical FoodN/A
Solarea Bio
Solarea BioMA - Waltham
1 program
SBD111 Probiotic Medical FoodN/A1 trial
Active Trials
NCT06614166Active Not Recruiting40Est. Jun 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Solarea BioSBD111 Probiotic Medical Food

Clinical Trials (1)

Total enrollment: 40 patients across 1 trials

NCT06614166Solarea BioSBD111 Probiotic Medical Food

Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults

Start: Jun 2024Est. completion: Jun 202540 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.